Recent studies have suggested that serial CRP measurements can help reclassify stable and unstable CAD patients undergoing coronary interventions by assessing their “residual inflammatory risk” in terms of long-term outcomes [5,21,30,31]. Here, CRP is linked to coronary artery disorder.